Researchers Better Understand RA-Associated ILD

Clinically significant ILD is believed to occur in 5%-10% of patients with RA, but robust data are lacking on how to best predict which patients face the highest risk for RA-associated ILD.

Related Keywords

Boston ,Massachusetts ,United States ,Brent Luedders ,Austinm Wheeler ,Gregory Campbell Mcdermott ,American College Of Rheumatology ,University Of Nebraska Medical Center ,Veterans Affairs Rheumatoid Arthritis ,American College ,Nebraska Medical Center ,Drilling Down ,Mass General Brigham Biobank ,Rheumatoid Arthritis Ra ,Heumatoid Arthritis Ra ,Genomics Genomic Medicine ,Genetics ,Biomarker ,Iological Marker ,Ulti Biomarker Disease Activity ,Bda ,Multibiomarker Disease Activity ,Idiopathic Pulmonary Fibrosis ,Epf ,Diopathic Pulmonary Fibrosis Ipf ,Pf Pulmonary Fibrosis ,Interstitial Lung Disease ,Lung ,Lung Fibrosis ,Pulmonary Fibrosis ,Pneumonia ,